Review article: Getting the balance right: Assessing causes and extent of vascular calcification in chronic kidney disease

Nephrology

Volumn 14, Issue 4, 2009, Pages 389-394

  Ketteler, Markus ^a   Biggar, Patrick H ^a  

^a KLINIKUM COBURG   (Germany)

Author keywords

Bone turnover; Calcium; Fetuin A; MGP 3; Vascular calcification

Indexed keywords

CALCIUM; FARNOQUINONE; FETUIN A; PHOSPHATE; PHYTOMENADIONE;

ARTERIOSCLEROSIS; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BONE DISEASE; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIAGNOSTIC IMAGING; HEMODIALYSIS; HUMAN; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

CALCINOSIS; HUMANS; RENAL CIRCULATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASCULAR DISEASES;

EID: 67650757651     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01149.x     Document Type: Review

References (45)

1. Schwarz U, Buzello M, Ritz E et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol. Dial. Transplant. 2000 15 : 218 23.
2. Gross ML, Meyer HP, Ziebart H et al. Calcification of coronary intima and media: Immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin. J. Am. Soc. Nephrol. 2007 2 : 121 34.
3. Shroff RC, McNair R, Figg N et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008 118 : 1748 57.
4. Moe SM, O'Neill KD, Duan D et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002 61 : 638 47.
5. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: New insights into an old phenomenon. Hypertension 2006 47 : 1027 34.
6. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N. Engl. J. Med. 2000 342 : 1478 83.
7. Oh J, Wunsch R, Turzer M et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002 106 : 100 105. (Pubitemid 34747448)
8. Shroff RC, Shah V, Hiorns MP et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol. Dial. Transplant. 2008 23 : 3263 71.
9. Bellasi A, Ferramosca E, Muntner P et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int. 2006 70 : 1623 8.
10. Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int. 2004 65 : 1790 94.
11. Nitta K, Akiba T, Suzuki K et al. Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens. Res. 2004 27 : 527 33.
12. Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2007 2 : 1241 8.
13. Stompór T, Rajzer M, Pasowicz M et al. Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis. Int. J. Artif. Organs 2006 29 : 736 44.
14. Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int. 2007 71 : 802 7.
15. Schlieper G, Krüger T, Djuric Z et al. Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int. 2008 74 : 1582 7.
16. Toussaint ND, Lau KK, Polkinghorne KR, Kerr PG. Measurement of vascular calcification using CT fistulograms. Nephrol. Dial. Transplant. 2007 22 : 484 90.
17. Hernández D, Rufino M, Bartolomei S et al. Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int. 2005 67 : 2015 20.
18. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 2000 87 : E10 17.
19. Giachelli CM. Vascular calcification mechanisms. J. Am. Soc. Nephrol. 2004 15 : 2959 64.
20. Reynolds JL, Joannides AJ, Skepper JN et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J. Am. Soc. Nephrol. 2004 15 : 2857 67.
21. Schafer C, Heiss A, Schwarz A et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 2003 112 : 357 66.
22. Heiss A, DuChesne A, Denecke B et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J. Biol. Chem. 2003 278 : 13333 41.
23. Jahnen-Dechent W, Schäfer C, Ketteler M, McKee MD. Mineral chaperones: A role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J. Mol. Med. 2008 86 : 379 89.
24. Reynolds JL, Skepper JN, McNair R et al. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J. Am. Soc. Nephrol. 2005 16 : 2920 30.
25. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 2003 361 : 827 33.
26. Stenvinkel P, Wang K, Axelsson J et al. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005 67 : 2383 92.
27. Wang AY, Woo J, Lam CW et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol. Dial. Transplant. 2005 20 : 1676 85.
28. Mathews ST, Singh GP, Ranalletta M et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002 51 : 2450 58.
29. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association between human fetuin-A and the metabolic syndrome: Data from the Heart and Soul Study. Circulation 2006 113 : 1760 67.
30. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997 386 : 78 81. (Pubitemid 27130923)
31. Geleijnse JM, Vermeer C, Grobbee DE et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J. Nutr. 2004 134 : 3100 105.
32. Koos R, Mahnken AH, Muhlenbruch G et al. Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography. Am. J. Cardiol 2005 96 : 747 9.
33. Block GA. Control of serum phosphorus: Implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis). Curr. Opin. Nephrol. Hypertens. 2001 10 : 741 7.
34. Ketteler M, Biggar PH, Brandenburg VM, Schlieper G, Westenfeld R, Floege J. Epidemiology, pathophysiology, and therapy of calciphylaxis. Dtsch. Arztebl. 2007 104 : A-3481-5.
35. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007 109 : 2823 31.
36. Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 2005 19 : 1093 104.
37. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002 62 : 245 52.
38. Block GA, Spiegel DM, Ehrlich J et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005 68 : 1815 24.
39. Qunibi W, Moustafa M, Muenz LR et al. CARE-2 Investigators. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am. J. Kidney Dis. 2008 51 : 952 65.
40. Barreto DV, Barreto Fde C, de Carvalho AB et al. Phosphate binder impact on bone remodeling and coronary calcification-results from the BRiC study. Nephron Clin. Pract. 2008 110 : c273 83.
41. Russo D, Miranda I, Ruocco C et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int. 2007 72 : 1255 61.
42. Lopez I, Aguilera-Tejero E, Mendoza FJ et al. Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol. J. Am. Soc. Nephrol. 2006 17 : 795 804.
43. Lopez I, Mendoza FJ, Aguilera-Tejero E et al. The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int. 2008 73 : 300 307.
44. Mizobuchi M, Finch JL, Martin DR, Slatopolsky E. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int. 2007 72 : 709 15.
45. Mathew S, Lund RJ, Chaudhary LR, Geurs T, Hruska KA. Vitamin D receptor activators can protect against vascular calcification. J. Am. Soc. Nephrol. 2008 19 : 1509 19.